カテゴリ： GlobalData, アメリカ, 企業調査

Hologic Inc (HOLX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7425
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：79
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Hologic Inc, Medical Equipment, Deal Details 13
Asset Purchase 13
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13
Venture Financing 14
Focal Therapeutics Raises USD3.8 Million in Venture Financing 14
Focal Therapeutics Raises USD7.8 Million in Venture Financing 15
Private Equity 16
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16
Partnerships 17
MeVis Medical Enters into Licensing Agreement with Hologic 17
Cynosure Enters into Distribution Agreement with Porter Instrument 18
Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19
Hologic Enters into Agreement with Royal Philips 20
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21
Faxitron Bioptics Enters into Agreement with Health Beacons 22
Seegene Enters into Agreement with Hologic 23
U.S. Department of Health and Human Services Enters into Agreement with Hologic 24
Bovie Medical Enters into Agreement with Hologic 25
Metamark Genetics Enters into Distribution Agreement with Hologic 26
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27
Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31
Equity Offering 32
Cynosure Completes Public Offering Of Class A Shares For US$58 Million 32
Debt Offering 33
Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33
Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 37
Asset Transactions 38
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 40
Acquisition 42
Hologic to Acquire Focal Therapeutics for USD125 Million 42
Hologic Acquires Faxitron Bioptics for USD85 Million 43
Hologic Acquires Cynosure in Tender Offer 44
Cynosure Acquires Ellman International for USD13 Million 46
Cynosure Completes Acquisition Of Palomar Medical Technologies For US$287 Million 47
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 49
Hologic Inc – Key Competitors 51
Hologic Inc – Key Employees 52
Hologic Inc – Locations And Subsidiaries 53
Head Office 53
Other Locations & Subsidiaries 53
Affiliate 56
Recent Developments 57
Strategy And Business Planning 57
Sep 27, 2018: Hologic to buy Focal Therapeutics for $125m 57
Financial Announcements 58
Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 58
May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 59
Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 61
Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the First Quarter of Fiscal 2018 63
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 64
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 66
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 68
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 69
Corporate Communications 71
Jul 31, 2018: Hologic Announces Chief Financial Officer Change 71
Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 72
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 73
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 74
Legal and Regulatory 75
Aug 01, 2018: US judge finds Fujifilm infringed on Hologic’s mammography patents 75
Product News 76
Apr 27, 2018: Leading Women’s Health Company Hologic Features Its Innovative Suite of Products at 2018 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting 76
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
Hologic Inc, Medical Equipment, Key Facts, 2017 2
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Deals By Market, 2012 to YTD 2018 10
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13
Focal Therapeutics Raises USD3.8 Million in Venture Financing 14
Focal Therapeutics Raises USD7.8 Million in Venture Financing 15
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16
MeVis Medical Enters into Licensing Agreement with Hologic 17
Cynosure Enters into Distribution Agreement with Porter Instrument 18
Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19
Hologic Enters into Agreement with Royal Philips 20
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21
Faxitron Bioptics Enters into Agreement with Health Beacons 22
Seegene Enters into Agreement with Hologic 23
U.S. Department of Health and Human Services Enters into Agreement with Hologic 24
Bovie Medical Enters into Agreement with Hologic 25
Metamark Genetics Enters into Distribution Agreement with Hologic 26
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27
Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31
Cynosure Completes Public Offering Of Class A Shares For US$58 Million 32
Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33
Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 37
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 40
Hologic to Acquire Focal Therapeutics for USD125 Million 42
Hologic Acquires Faxitron Bioptics for USD85 Million 43
Hologic Acquires Cynosure in Tender Offer 44
Cynosure Acquires Ellman International for USD13 Million 46
Cynosure Completes Acquisition Of Palomar Medical Technologies For US$287 Million 47
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 49
Hologic Inc, Key Competitors 51
Hologic Inc, Key Employees 52
Hologic Inc, Other Locations 53
Hologic Inc, Subsidiaries 53
Hologic Inc, Affiliate 56

List of Figures
Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Hologic Inc (HOLX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • VisionQuest Biomedical LLC：製品パイプライン分析
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package; DR-RACS is an automated …
  • Torrent Power Limited：企業の戦略・SWOT・財務情報
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sirona Biochem Corp (SBM)：企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It offers cosmeceutical programs such as development of anti-aging and depigmenting agents, …
  • TVEL Fuel Co：企業の戦略的SWOT分析
    TVEL Fuel Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • First Solar Inc (FSLR)-エネルギー分野：企業M&A・提携分析
    Summary First Solar, Inc. (First Solar) is a provider of photovoltaic (PV) solar energy solutions. It designs, manufactures and sells PV solar modules with an advanced thin-film semiconductor technology; and also develops, designs, constructs and sells PV solar power systems. The company uses its Cd …
  • NextEra Energy Resources LLC-エネルギー分野：企業M&A・提携分析
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • Kawasaki Kisen Kaisha, Ltd.：企業の戦略・SWOT・財務情報
    Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MannKind Corp (MNKD)：医療機器：M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Xencor, Inc.：企業のM&A・事業提携・投資動向
    Xencor, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Xencor, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • CaixaBank SA：戦略・SWOT・企業財務分析
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Key Petroleum Ltd (KEY)：石油・ガス：M&Aディール及び事業提携情報
    Summary Key Petroleum Ltd (Key Petroleum) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company carries out projects such as Canning Basin and Perth Basin. It holds interest in exploration permits such as EP 438, EP 448, EP 104/ …
  • SPR Coffee：企業の戦略・SWOT・財務情報
    SPR Coffee - Strategy, SWOT and Corporate Finance Report Summary SPR Coffee - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ALLETE Inc (ALE)-エネルギー分野：企業M&A・提携分析
    Summary ALLETE, Inc. (ALLETE) is an energy company that operates varied businesses in the energy sector. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. It provides energy in the upper Midwest in the US; and inves …
  • Dragon Oil Plc：企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • AstraZeneca Plc (AZN)：企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hurricane Energy plc (HUR)：企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Toleranzia AB-製薬・医療分野：企業M&A・提携分析
    Summary Toleranzia AB (Toleranzia) is a developer of platform technology for the treatment of autoimmune diseases. The company develops and offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein for t …
  • Seattle Genetics Inc (SGEN)-製薬・医療分野：企業M&A・提携分析
    Summary Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate indicated for the treatment of relapsed …
  • ConocoPhillips (COP)：企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Railroad Passenger Corporation：企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆